yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q53649433-540D6AFE-A53A-4E60-B0BE-D31FCEAF8B03
Q53649433-540D6AFE-A53A-4E60-B0BE-D31FCEAF8B03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53649433-540D6AFE-A53A-4E60-B0BE-D31FCEAF8B03
Renal cell carcinoma: An update for the practicing urologist.
P2860
Q53649433-540D6AFE-A53A-4E60-B0BE-D31FCEAF8B03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53649433-540D6AFE-A53A-4E60-B0BE-D31FCEAF8B03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ba6c5a36a7c3b50fbc6e8a1fe762f2f12a18c40f
P2860
Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival.